This article relies largely or entirely on a single source . Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources. Find sources: "4-Bromo-3,5-dimethoxyamphetamine" – news · newspapers · books · scholar · JSTOR (September 2019) |
| | |
| | |
| Clinical data | |
|---|---|
| Other names | 4-Bromo-3,5-dimethoxyamphetamine; 3,5-Dimethoxy-4-bromoamphetamine; 4,3,5-DOB |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C11H16BrNO2 |
| Molar mass | 274.158 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
4-Bromo-3,5-dimethoxyamphetamine (4-Br-3,5-DMA) is a lesser-known psychoactive drug of the phenethylamine, amphetamine, and 3C families related to mescaline. [1] It was first synthesized by Alexander Shulgin. [1] In his 1997 book PiHKAL (Phenethylamines I Have Known and Loved), the dose range is listed as 4 to 10 mg and the duration as 8 to 12 hours. [1] It has been reported to be definitely psychoactive and to produce pain relief, numbing of extremities, and barely perceptible sensory distortions if any. [1] However, it is not clear that 4-Br-3,5-DMA is a psychedelic, and may instead be some other kind of drug. [1]
| | This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it. |